Skip to main content
SpringerLink
Log in

Naproxcinod: stiff competition for osteoarthritis

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. NicOx S.A..NicOx presents phase 3 quality of life data for naproxcinod at ISPOR. Media Release: 19 May 2009. Available from: URL: http://www.nicox.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naproxcinod: stiff competition for osteoarthritis. Pharmacoecon. Outcomes News 579, 4 (2009). https://doi.org/10.2165/00151234-200905790-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905790-00006

Keywords

Search

Navigation